Effects of Tango on Functional Mobility and QOL in Parkinson's Disease

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030200059

Enrollment

Registered

2020-06-29

Start date

2020-06-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease Parkinson Disease

Interventions

Single Case Experimental Designs A Baseline 3 Times Per Week B Intervention Tango Therapy 3 Times Per Week A Baseline 3Times Per Week

Tango Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Parkinson Disease

Exclusion criteria

Exclusion criteria: Non Parkinon Disease

Design outcomes

Primary

Measure	Time frame
Time up and Go Test PDQ39 Functional Balance Scale (Nishimori, 2003)	—

Secondary

Measure	Time frame
Self Esteem Scale(Ito, 2005) SHS(Shimai et al, 2003) Life Satisfaction Scale(Kadono, 1994) Objective evaluation, subjective evaluation MMSE(Mini-Mental State Examination) PFS16	—

Contacts

Public ContactAbeta Kyoko

Graduate School of Human Sciences, Waseda University

k.abeta@akane.waseda.jp+81-4-2947-6848

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026